TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 0 | 0 | 27 | 106 | 98 | 65 | 59 | 
| P | %wins | 67 | 67 | 100 | 100 | 100 | 67 | 83 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/11 18:23  | 12/21/10  | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Afting Ernst-Guenter | CA | D | P | 50 | 0.1400 | 0 | 360 | 65 | 918 | D | -56 | -89 | -89 | -67 | -67 | -33 | -33 | -33 | 0 | 0 | 50 | 50 | 15 | 85 | |
5/6/08 18:32  | 5/2/08  | SQNM | Sequenom Inc | DE | Electr | LabEq | Measuring & Controlling Devic | Afting Ernst-Gunter | CA | D | P.m | 67 | 7.66 | 2 | 9 | 25 | 44 | D | 278 | 117 | -11 | -13 | 21 | 34 | 40 | 22 | 1 | 2 | 21 | 172 | 134 | -48 | |
8/10/06 10:41  | 8/8/06  | SQNM | Sequenom Inc | DE | Health | Biolab | Commercial Physical & Biologi | Afting Ernst-Gunter | CA | D | P.m | 26 | 1.76 | 0 | 15 | 73 | 35 | D | -24 | -32 | -13 | -6 | 9 | 26 | 18 | 9 | -1 | -1 | 9 | 95 | 146 | 159 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |